NAMS – newamsterdam pharma company n.v. - ordinary shares (US:NASDAQ)
Stock Stats
News
NewAmsterdam Pharma (NASDAQ: NAMS) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results [Yahoo! Finance]
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Form ARS NewAmsterdam Pharma Co For: Dec 31
Form DEF 14A NewAmsterdam Pharma Co For: Jun 05
Form 8-K NewAmsterdam Pharma Co For: May 09
Form 10-Q NewAmsterdam Pharma Co For: Mar 31
Form 3 NewAmsterdam Pharma Co For: Apr 25 Filed by: JONES WILLIAM A JR
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.